Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Organizations, Nonprofit: Organizations which are not operated for a profit and may be supported by endowments or private contributions.Cookbooks as Topic: Set of instructions about how to prepare food for eating using specific instructions.Licensure: The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.Foramen Ovale, Patent: A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.Professional Corporations: Legally authorized corporations owned and managed by one or more professionals (medical, dental, legal) in which the income is ascribed primarily to the professional activities of the owners or stockholders.Drugs, Chinese Herbal: Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.Engineering: The practical application of physical, mechanical, and mathematical principles. (Stedman, 25th ed)Voluntary Health Agencies: Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.Medicine, Traditional: Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals (SPIRITUAL THERAPIES); PHYTOTHERAPY; and other treatments which may not be explained by modern medicine.Multimedia: Materials, frequently computer applications, that combine some or all of text, sound, graphics, animation, and video into integrated packages. (Thesaurus of ERIC Descriptors, 1994)Information Storage and Retrieval: Organized activities related to the storage, location, search, and retrieval of information.Hypermedia: Computerized compilations of information units (text, sound, graphics, and/or video) interconnected by logical nonlinear linkages that enable users to follow optimal paths through the material and also the systems used to create and display this information. (From Thesaurus of ERIC Descriptors, 1994)Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Software: Sequential operating programs and data which instruct the functioning of a digital computer.Computer-Assisted Instruction: A self-learning technique, usually online, involving interaction of the student with programmed instructional materials.Algorithms: A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.Pattern Recognition, Visual: Mental process to visually perceive a critical number of facts (the pattern), such as characters, shapes, displays, or designs.Photic Stimulation: Investigative technique commonly used during ELECTROENCEPHALOGRAPHY in which a series of bright light flashes or visual patterns are used to elicit brain activity.Form Perception: The sensory discrimination of a pattern shape or outline.War: Hostile conflict between organized groups of people.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Cellular Phone: Analog or digital communications device in which the user has a wireless connection from a telephone to a nearby transmitter. It is termed cellular because the service area is divided into multiple "cells." As the user moves from one cell area to another, the call is transferred to the local transmitter.Gulf War: United Nations' action to intervene in conflict between the nation of Kuwait and occupying Iraqi forces, occurring from 1990 through 1991.Stars, Celestial: Large bodies consisting of self-luminous gas held together by their own gravity. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)Foramen Ovale, Patent: A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.Text Messaging: Communication between CELL PHONE users via the Short Message Service protocol which allows the interchange of short written messages.War Crimes: Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.Persian Gulf Syndrome: Unexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. (Nature 1994 May 5;369(6475):8)American Civil War: 1861-1865 conflict between the Union (Northern states) and the 11 Southern states that seceded and were organized as the Confederate States of America.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Inventors: Persons or entities that introduce a novel composition, device, or process, as well as improvements thereof.Intellectual Property: Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)Inventions: A novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.History, 18th Century: Time period from 1701 through 1800 of the common era.Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.Therapeutic Misconception: Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.History, 20th Century: Time period from 1901 through 2000 of the common era.History, 17th Century: Time period from 1601 through 1700 of the common era.History, 19th Century: Time period from 1801 through 1900 of the common era.Intellectual Property: Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.Drug Industry: That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.Copyright: It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)Outsourced Services: Organizational activities previously performed internally that are provided by external agents.Commerce: The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)Plagiarism: Passing off as one's own the work of another without credit.Technology Transfer: Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Diet, Sodium-Restricted: A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed)Sodium, Dietary: Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.Food: Any substances taken in by the body that provide nourishment.Sodium Chloride: A ubiquitous sodium salt that is commonly used to season food.Sodium: A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.Food Supply: The production and movement of food items from point of origin to use or consumption.Blood Pressure: PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.Flour: Ground up seed of WHEAT.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Radioactive Fallout: The material that descends to the earth or water well beyond the site of a surface or subsurface nuclear explosion. (McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed)Beginning of Human Life: The point at which religious ensoulment or PERSONHOOD is considered to begin.Academic Medical Centers: Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Selection, Genetic: Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.Research: Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)Judaism: The religion of the Jews characterized by belief in one God and in the mission of the Jews to teach the Fatherhood of God as revealed in the Hebrew Scriptures. (Webster, 3d ed)Immunoglobulin Variable Region: That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions.Personhood: The state or condition of being a human individual accorded moral and/or legal rights. Criteria to be used to determine this status are subject to debate, and range from the requirement of simply being a human organism to such requirements as that the individual be self-aware and capable of rational thought and moral agency.Copyright: It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)Intellectual Property: Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)Chamaecrista: A plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Biography as Topic: A written account of a person's life and the branch of literature concerned with the lives of people. (Harrod's Librarians' Glossary, 7th ed)HumanitiesBooksBiographyPiper betle: A plant genus of the family PIPERACEAE that is indigenous in the Indian Malay region and cultivated in Madagascar, and the West Indies. It contains chavibetol, chavicol and cadinene. The leaf is chewed as a stimulant, antiseptic and sialogogue. The common name of betel is also used for ARECA.Literature, ModernSulfonesPurines: A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.Pharmacies: Facilities for the preparation and dispensing of drugs.Delegation, Professional: The process of assigning duties to a subordinate with lesser qualifications.Pharmacy: The practice of compounding and dispensing medicinal preparations.PiperazinesPrescription Drugs: Drugs that cannot be sold legally without a prescription.Education, Pharmacy: Formal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.Drug Prescriptions: Directions written for the obtaining and use of DRUGS.Tertiary Healthcare: Care of a highly technical and specialized nature, provided in a medical center, usually one affiliated with a university, for patients with unusually severe, complex, or uncommon health problems.Libido: The psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). It may also connote the psychic energy associated with instincts in general that motivate behavior.SulfonesErectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.Purines: A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.Phosphodiesterase 5 Inhibitors: Compounds that specifically inhibit PHOSPHODIESTERASE 5.Australia: The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.Penile Erection: The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions.PiperazinesPhosphodiesterase Inhibitors: Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.Pharmacies: Facilities for the preparation and dispensing of drugs.

Disease gene patents: overcoming unethical constraints on clinical laboratory medicine. (1/276)

The rapidly growing number of disease gene patents--patents that claim all methods for diagnosis of a particular genetic condition--threatens the ability of physicians to provide medical care to their patients. In the past, patented diagnostic tests were made broadly available to the medical community in the form of test kits or licenses to use the patented test. Disease gene tests, however, are being monopolized by a small number of providers. Monopolization of medical testing services: (a) threatens to restrict research activities; (b) creates unacceptable conflicts of interest; (c) may reduce patient access to testing; (d) may lead to inequitable extensions of patent terms on tests and related discoveries; and (e) grants to patent holders the ability to dictate the standard of care for testing, and to otherwise interfere with the practice of medicine. Because of the risks raised by monopolization, amendment of the patent law to require compulsory licensing of physicians providing medical services is recommended.  (+info)

Essential drugs in the new international economic environment. (2/276)

Recent global developments in the regulation of trade and intellectual property rights threaten to hinder the access of populations in developing countries to essential drugs. The authors argue for state intervention in the health and pharmaceutical markets in order to guarantee equitable access to these products.  (+info)

The future of molecular genetic testing. (3/276)

The potential applications for genetic testing are immense, with most diseases having some aspect influenced by, if not directly caused by, changes in the genome of the patient. The translation of genetic information into medical applications will be influenced by our understanding of the human genome, technological advances, and social, ethical, and legal issues surrounding genetic testing. With time, new genetic information will be translated into clinical tests for the diagnosis of current illness and prediction of future disease risk, and will be used for the development of genetically directed therapies and preventive interventions. Most genetic testing will be highly automated, with only rare genetic disease tests performed manually. The challenge for the clinical genetic laboratory is to keep pace with this information explosion to provide state-of-the-art genetic testing and to ensure that the genetic test results are used in a morally, ethically, and socially responsible way.  (+info)

Pharmaceutical policies in Canada: another example of federal-provincial discord. (4/276)

Pharmaceutical policy in Canada is set at both the federal and provincial levels of government. The federal government is responsible for intellectual property rights of manufacturers (patents) and the initial approval and labelling of prescription drugs and for ensuring overall market competitiveness. The provincial government has responsibility and jurisdiction over the funding of all health care services, including pharmaceuticals. Various interactions between the pharmaceutical industry, the federal and provincial governments and consumers have shaped the current landscape for prescription drugs in Canada. One key failing of the system is that the federal government is almost completely insulated from the impact of its policies because, although it regulates drug prices, it does not buy any drugs. In contrast, provincial governments have no jurisdiction over market competitiveness or pricing, yet end up paying for most of the drug expenditures incurred.  (+info)

Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry. (5/276)

OBJECTIVE: To analyze the effect of multiple-source drug entry on price competition after patent expiration in the pharmaceutical industry. DATA SOURCES: Originators and their multiple-source drugs selected from the 35 chemical entities whose patents expired from 1984 through 1987. Data were obtained from various primary and secondary sources for the patents' expiration dates, sales volume and units sold, and characteristics of drugs in the sample markets. STUDY DESIGN: The study was designed to determine significant factors using the study model developed under the assumption that the off-patented market is an imperfectly segmented market. PRINCIPAL FINDINGS: After patent expiration, the originators' prices continued to increase, while the price of multiple-source drugs decreased significantly over time. By the fourth year after patent expiration, originators' sales had decreased 12 percent in dollars and 30 percent in quantity. Multiple-source drugs increased their sales twofold in dollars and threefold in quantity, and possessed about one-fourth (in dollars) and half (in quantity) of the total market three years after entry. CONCLUSION: After patent expiration, multiple-source drugs compete largely with other multiple-source drugs in the price-sensitive sector, but indirectly with the originator in the price-insensitive sector. Originators have first-mover advantages, and therefore have a market that is less price sensitive after multiple-source drugs enter. On the other hand, multiple-source drugs target the price-sensitive sector, using their lower-priced drugs. This trend may indicate that the off-patented market is imperfectly segmented between the price-sensitive and insensitive sector. Consumers as a whole can gain from the entry of multiple-source drugs because the average price of the market continually declines after patent expiration.  (+info)

Pending resolution: the question of who owns DNA. (6/276)

With the emergence of the Human Genome Project and its private counterparts, the U.S. Patent and Trademark Office has begun receiving applications for the patenting of genes and genetic sequences. Earlier patent decisions regarding similar scientific advances limited patents to organisms "made by the hand of man," which would seem to remove discovered genes from patent protection. But many applicants have been successful in attaining patents for genes based on their ability to demonstrate the ultimate utility of the gene, for instance in medicine. One controversy regarding genomic patenting, however, is that patents apparently have been granted for mere gene fragments devoid of much demonstrable utility. Furthermore, critics fear that gene patenting will retard research by squelching scientists' ability to share findings freely.  (+info)

Patenting human genetic material: refocusing the debate. (7/276)

The biotechnology industry has become firmly established over the past twenty years and gene patents have played an important part in this phenomenon. However, concerns have been raised over the patentability of human genetic material, through public protests and international statements, but to little effect. Here we discuss some of these concerns, the patent authorities' response to them, and ways in which to address these issues and to move the debate forward using current legal structures.  (+info)

Patent protection of pharmaceuticals. (8/276)

Patenting of biologically active compounds by academic institutions is discussed, with emphasis on patents for already known compounds.  (+info)

*American Academy of Anti-Aging Medicine

However, a 2006 review of anti-aging medicine notes that of the researchers who are interested in this topic, the "vast ... "hormone therapies are the new patent medicines - cure-alls embraced by a too-trusting public." A 2003 review that was published ... hormone in anti-aging medicine which published in Clinical Interventions in Aging noted the opinions of the A4A on this topic, ...

*Analog ear

with product names of "Speech Thing" and "Voice Master". A number of U.S. (and foreign) patents on topics related to Stewart's ... This handbook is singled out as a major source of information on speech and hearing, word recognition, and other topics as well ... Many reports, articles, and patents followed the research as cited in the reports listed here. The last full report employed a ... The concept of the "neural analyzer" as an extension of cochlear patterns is discussed in U. S. patent 3,387,093, "Speech ...

*Ladder Golf

This is one in a long string of patents on the topic. The game is played by throwing a bola of two golf balls connected with a ... Reid sold his patent to Ladder Golf LLC, recorded in the patent office in March 2005, and the company began manufacturing the ... Patent Assignment #6308956, United States Patent and Trademark Office. Retrieved on 2009-05-30. Seabaugh, Julie (May 24, 2006 ... A "ball and ladder game" had been patented in 2001 by Pennsylvanian Robert G. Reid, a postman who had played the game with his ...

*List of patent claim types

... www.iponz.govt.nz/cms/patents/patent-topic-guidelines/2004-business-updates/2009-business-updates/guidelines-for-the- ... Patent searchers have the problem, when searching for specific chemicals in patents, of trying to find all patents with Markush ... Under U.S. patent law, omnibus claims are categorically disallowed in utility patents, and examiners will reject them as ... This is a list of special types of claims that may be found in a patent or patent application. For explanations about ...

*Technology and Culture

Occasionally, the journal publishes thematic issues; topics have included patents, gender and technology, and ecology. ... To adequately address these topics in all their complexity, a truly interdisciplinary approach was needed. And this was to be ...

*Jeremy Carr

Patent Pending - Topic (2015-11-06), Anti-Everything (feat. Jeremy Carr), retrieved 2016-03-15 ... Also in 2009, Jeremy participated in the creation of the album Attack of the Awesome with pop punk band, Patent Pending. Jeremy ... Tanya Morgan & Jeremy Carr) 2009: "Anti-Everything" (Patent Pending feat. Jeremy Carr) 2010: "Until The Search Is Over" (DJ ...

*A. Aneesh

Topic: Patenting Life, 17 October 2010 Interviewed on the Gary Null Radio Show on the topic of globalization and poverty ( ...

*Albert Fonó

He had 46 patents in 20 topics of research, including a steam boiler and an air compressor for mines. In 1915 he devised a ... in a German patent application. In an additional patent application he adapted the engine for subsonic speed. The patent was ... Finally, in 1960, the American Rocket Society reviewed his patents and acknowledged him as the inventor of the jet engine.[ ... Hungarian mechanical engineer who was one of the early pioneers of turbojet and ramjet propulsion and was first to patent a ...

*Truss rod

List of guitar-related topics US patent 1446758, Thaddeus McHugh, "Neck for musical instruments", issued 1923-02-27 Patent on ... US patent 964660, George D. Laurian, "Stringed musical instrument", issued 1910-07-19 A patent on instrument that is "designed ... The first truss rod patent was applied for by Thaddeus McHugh, an employee of the Gibson company, in 1921, though the idea of a ... In fact, the 1923 patent touts the possibility of using cheaper materials as an advantage of the truss rod. Before truss rods, ...

*Mind map

And there is a patent about automatically creating sub-topics in mind maps. Mind-mapping software can be used to organize large ... Buzan suggests the following guidelines for creating mind maps: Start in the center with an image of the topic, using at least ...

*Otto Julius Zobel

However, none of Zobel's patents or articles appear to discuss this topic. It is unclear whether he actually designed anything ... Zobel, O J, Wave Filter, U.S. Patent 1,538,964, filed 15 Jan 1921, issued 26 May 1925. Zobel's U.S. Patent 1,538,964 (p.4, l.23 ... Patent 2,767,380, filed 30 Sept 1952, issued 16 Oct 1956. Zobel, O J, Microwave Filter, U.S. Patent 2,623,120, filed 20 April ... The last of his prolific list of patents occurred for Bell Labs in the 1950s, by which time he was residing in Morristown, New ...

*Soft IP

... www.epo.org/topics/patent-system/scenarios-for-the-future/scenario4.html. ... A patent may, at the request of the patent owner, be endorsed LOR in the UK and/or Germany. The request is made by the patent ... An innocent infringer is one who did not know of the patent or could not reasonably be expected to have known of the patent and ... In the field of patents there is effectively a Soft IP system in UK and Germany where patents may be endorsed "Licenses of ...

*Krishna Bharat

When experts agree: using non-affiliated experts to rank popular topics US Patent 7346604 Method for ranking hypertext search ... results by analysis of hyperlinks from expert documents and keyword scope US Patent 6725259 Ranking search results by reranking ...

*Vladimir Igorevich Gurevich

... more than 200 journal papers and over 100 patents on the topic of relays. V. I. Gurevich was born in Kharkov, Ukraine, in 1956 ... "Selected Patents by Vladimir Gurevich". gurevich-publications.com. Retrieved 2016-12-02. Official website. ...

*Kenneth Adelman

... pharmaceutical industry HIV/AIDS drug intellectual property patents and other topics linked to Edelman Public Relations clients ...

*Prepay mobile phone

In 2006 Swisscom celebrated ten years with its product and service "NATEL(R) easy" which also holds a patent on the topic " ...

*Open Source Information System

A database of over 10 million titles on scientific and technical topics, including patents, standards, military equipment and ... TCOM (Telecommunications) contains abstracts and complete articles on telecommunications related topics. TEL (Technical ...

*Ting Wu

... has four patents pending on topics related to biomedical research and health applications "Oligonucleotide Trapping " ( ... "Chao-ting Wu Patents and Applications". Harvard University Office of Technology Development. Retrieved 3 Nov 2013. Carolyn Y. ... She has been interviewed by the Boston Globe on the topic of inventors. In the context of TEDx and Google "Solve for X" she has ... she uses empirically engaging topics like prenatal diagnosis and the biological challenges of Mars colonization. She is ...

*William C. Pfefferle

Pfefferle also held numerous other patents concerning the catalytic method, combustion and related topics. A Compact Catalytic ... This is the basic patent in a group of over ten covering technology for burning fuels in continuous combustion systems (such as ... American Chemical Society's Industrial Innovation Awards Pfefferle held over 100 patents including on two major processes, ...

*XRS Corporation

"Transport Topics", October 10, 2010 "Recent patent infringement suits filed in the Eastern District of Texas". April 15, 2009. ... On April 7 2009, XRS Corporation was sued among some other defendants over patent infringement. XRS introduced an all-mobile ...

*Bioprospecting

Topics include: Monsanto's species-wide patent on all genetically modified soybeans (EP0301749); Synthetic Biology Patents ( ... Louis Pasteur patented a "yeast" which was "free from disease" (patent #141072). Patents covering biological inventions have ... The patent on the enola bean (now revoked) was an example of this sort of patent. The intellectual property laws of the US also ... While obtaining a patent on a naturally occurring organism as previously known or used is not possible, patents may be taken ...

*Connecticut River

"The Warwick Patent". Colonial Records & Topics. CT State Library. Retrieved August 9, 2016. Barrows, Charles Henry (1911). The ... the Warwick Patent of 1631. The patent, however, had been physically lost, and the annexation was almost certainly illegal. The ...

*Journal of Technology Law & Policy

Topics include, but are not limited to patents, copyrights, trademarks, trade secrets, antitrust, information privacy, and ...

*Windows Media DRM

U.S. Patent 7,010,808,Google Patent Microsoft Windows Media DRM home page FairUse4WM topic-thread on doom9-net forums. ...

*Groklaw

Other topics covered included software patents, DMCA, the actions of the RIAA against alleged illegal file sharers, and actions ... Almost every article also attracted an "Off Topic" thread, where a diverse range of topics was discussed. According to a 2003 ... Additional topics included later lawsuits by The SCO Group against Daimler Chrysler, Autozone, and Novell, the countersuit by ... Subsequent to this decision, new patent and copyright based attacks on the Android operating system led to Jones resuming an ...

*Robot research initiative

The research topic is "development of core and application technologies on high dynamic parallel cable robotics." Prof. Jong Oh ... It was the first automatic production line application of Korean patent. The technology was developed in 1996 and operated in ...

*Oblon

Additionally, the firm publishes two other blogs on IP related topics including one on Design Patents (protectingdesigns.com) ... The law firm performs trademark and patent prosecution, as well as litigation and Post-Grant Proceedings before the Patent ... The firm's Post-Grant Patent practice group publishes the Patents Post Grant blog, including the commentary of partners Stephen ... v. Shoketsu Kinzoku Kogyo Kabushiki Co., as well as Charles "Chico" Gholz, in the field of patent interference practice. ...
0055] The various illustrative slings described herein may be employed with any suitable sling delivery system. By way of example, the slings of the invention may be employed with any delivery systems appropriate for treating urinary incontinence. Such delivery systems include, for example, those delivery systems configured for supra-pubic, pre-pubic, transvaginal or transobturator approaches. Without limitation, exemplary delivery systems, methodologies, sling, sling attachments that may be employed can be found in U.S. patent application Ser. No. 10/460,112, U.S. patent application Ser. No. 10/093,498, U.S. patent application Ser. No. 09/916,983, U.S. patent application Ser. No. 10/093,398, U.S. patent application Ser. No. 10/093,450, U.S. patent application Ser. No. 10/094,371, U.S. patent application Ser. No. 10/092,872, U.S. patent application Ser. No. 09/916,983, U.S. provisional patent application Ser. No. 60/465,722, U.S. patent application Ser. No. 10/094,352, U.S. patent application ...
Korean Intellectual Property Office 209 854 Extension of the Patent Prosecution Highway Pilot Program between the USPTO and the CIPO 210 855 Revised Requirements for Requesting Participation in the Patent Prosecution Highway Pilot Program in the USPTO (between the USPTO and the EPO) 211 858 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Danish Patent and Trademark Office 212 864 Extension Of the Patent Prosecution Highway Pilot Program Between the USPTO and the UKIPO 213 865 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and European Patent Office 214 869 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and IP Australia 215 874 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Korean Intellectual Property Office 216 879 Patent Prosecution Highway Pilot Program between the United States Patent and ...
0001] This application claims priority to U.S. Provisional Patent Application Ser. No. 60/862,743, filed Oct. 24, 2006; and claims priority to and is a continuation of: U.S. Patent Publication No. 20080097908 filed as U.S. Utility patent application Ser. No. 11/876,689 on Oct. 22, 2007; U.S. Patent Publication No. 20080097909 filed as U.S. Utility patent application Ser. No. 11/876,695 on Oct. 22, 2007; U.S. Patent Publication No. 20080097551 filed as U.S. Utility patent application Ser. No. 11/876,708 on Oct. 22, 2007; U.S. Patent Publication No. 20080103554 filed as U.S. Utility patent application Ser. No. 11/876,711 on Oct. 22, 2007; U.S. Patent Publication No. 20080103370 filed as U.S. Utility patent application Ser. No. 11/876,713 on Oct. 22, 2007; U.S. Patent Publication No. 20080097910 filed as U.S. Utility patent application Ser. No. 11/876,719 on Oct. 22, 2007; U.S. Patent Publication No. 20080215360 filed as U.S. Utility patent application Ser. No. 11/876,725 on Oct. 22, 2007; U.S. ...
TY - JOUR. T1 - Patent application trends of induced pluripotent stem cell technologies in the United States, Japanese, and European applications. AU - Morita, Yasushi. AU - Okura, Hanayuki. AU - Matsuyama, Akifumi. PY - 2019/1/1. Y1 - 2019/1/1. N2 - Patent application trends were investigated for induced pluripotent stem cell (iPSC) technologies, particularly disease-specific cell technologies related to iPSCs, in the U.S., Japanese, and European applications during 2017. The number of patent applications for iPSC technologies was 1516 in the United States, 895 in Japan, and 420 in Europe, with 5% of applications for disease-specific cell technologies. In contrast, the percentages of patent applications for iPSC preparation and differentiation technologies were 17% and 23%, respectively. Patent applications for disease-specific cell technologies were classified into four technical fields and 14 disorder groups. In the technical fields, patent applications for genetically engineered cell ...
Trademark is a distinctive logo, phrase, or design such as "Dunkin Donuts®" or "Microsoft®" that uniquely identifies a particular commercial product or series of products with a specific commercial supplier. The symbols ™ or ® are often used to alert the public to the trademark. Anyone claiming ownership of a trademark can use ™ to alert others to their ownership of a trademark. The ® symbol on the other hand indicates that the trademark has been officially registered with the United States Patent and Trademark Office. Federal registration of a trademark is useful in preventing foreign infringement on the trademark and in obtaining registration rights to the trademark outside the United States.. ...
Federal Register: June 15, 1998 (Volume 63, Number 114)] [Notices] [Page 32639-32645] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr15jn98-27] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE Patent and Trademark Office [Docket No. 980605148-8148-01] Request for Comments on Interim Guidelines for Examination of Patent Applications Under the 35 U.S.C. 112 para. 1 ``Written Description Requirement AGENCY: Patent and Trademark Office, Commerce. ACTION: Notice and request for public comments. ----------------------------------------------------------------------- SUMMARY: The Patent and Trademark Office (PTO) requests comments from any interested member of the public on the following interim guidelines. These guidelines will be used by PTO personnel in their review of biotechnological patent applications for compliance with the ``written description requirement of 35 U.S.C. 112 para. 1. Although the guidelines are ...
OSENI is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. PREVACID is a trademark registered in the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U. S. A., Inc. and used under license by Takeda Pharmaceuticals America, Inc.. PREVPAC and PREVACID are trademarks of Takeda Pharmaceuticals U. S. A., Inc. registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. Rozerem is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. TRINTELLIX is a trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc.. ULORIC is a trademark of Teijin Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals ...
Downloadable ! Author(s): Petra Moser. 2003 Abstract: This paper introduces a new internationally comparable data set that permits an empirical investigation of the effects of patent law on innovation. The data have been constructed from the catalogues of two 19th century world fairs: the Crystal Palace Exhibition in London, 1851, and the Centennial Exhibition in Philadelphia, 1876. They include innovations that were not patented, as well as those that were, and innovations from countries both with and without patent laws. I find no evidence that patent laws increased levels of innovative activity but strong evidence that patent systems influenced the distribution of innovative activity across industries. Inventors in countries without patent laws concentrated in industries where secrecy was effective relative to patents, e.g., food processing and scientific instruments. These results suggest that introducing strong and effective patent laws in countries without patents may have stronger effects on
49. Use of one of associated or substantially identical trademarks equivalent to use of another.⎯(1) Where under the provisions of this Act. the use a registered trademark is required to be proved for any purpose, the Tribunal may, if and so far as it shall think right, accept the use of a registered associated trademark, or the trademark with additions or alterations not substantially affecting its identity, as an equivalent for the use required to be proved. (2) The use of the whole of a registered trademark shall for the purposes of this Act be deemed to be also a use of any trademark being a part thereof and registered in accordance with sub-section (1) of section 12 of this Act in the name of the same proprietor. 50. Use of trademark for export trade and use when form of trade connection changes :⎯(1) The application in Bangladesh of a trademark to goods or services to be exported from Bangladesh and any other law done in Bangladesh in relation to goods or services, to be so exported ...
Coordinates: 35°40′15.56″N 139°44′45.15″E / 35.6709889°N 139.7458750°E / 35.6709889; 139.7458750 The Japan Patent Office (特許庁, Tokkyochō, JPO) is a Japanese governmental agency in charge of industrial property right affairs, under the Ministry of Economy, Trade and Industry. The Japan Patent Office is located in Kasumigaseki, Chiyoda, Tokyo and is one of the worlds largest patent offices. The Japan Patent Offices mission is to promote the growth of the Japanese economy and industry by administering the laws relating to patents, utility models, designs, and trademarks. (Copyright affairs are administered by the Agency for Cultural Affairs.) The Japan Patent Office is headed by a commissioner and consists of seven departments: General Affairs Department Trademark, Design, and Administrative Affairs Department, in charge of examining trademark right applications, design right applications and formalities check of all applications including patent applications First ...
WASHINGTON (AP) - The Supreme Court on Monday struck down part of a law that bans offensive trademarks, ruling in favor of an Asian-American rock band called the Slants and giving a major boost to the Washington Redskins in their separate legal fight over the team name.. The justices were unanimous in saying that the 71-year-old trademark law barring disparaging terms infringes free speech rights guaranteed in the Constitutions First Amendment.. "It offends a bedrock First Amendment principle: Speech may not be banned on the ground that it expresses ideas that offend," Justice Samuel Alito said in his opinion for the court.. Slants founder Simon Tam tried to trademark the band name in 2011, but the U.S. Patent and Trademark Office denied the request on the ground that it disparages Asians. A federal appeals court in Washington later said the law barring offensive trademarks is unconstitutional and the Supreme Court agreed.. The Redskins made similar arguments after the trademark office ruled in ...
Trademark applications filed are applications to register a trademark with a national or regional Intellectual Property (IP) office. A trademark is a distinctive sign which identifies certain goods or services as those produced or provided by a specific person or enterprise. A trademark provides protection to the owner of the mark by ensuring the exclusive right to use it to identify goods or services, or to authorize another to use it in return for payment. The period of protection varies, but a trademark can be renewed indefinitely beyond the time limit on payment of additional fees. Direct nonresident trademark applications are those filed by applicants from abroad directly at a given national IP office.This page has the latest values, historical data, forecasts, charts, statistics, an economic calendar and news for Trademark applications - direct nonresident in Mali.
Colombia has reached an agreement with the USPTO to participate in the Patent Prosecution Highway, becoming the first South American country to gain such status. With Colombias sturdy economy and confident move into the global marketplace, this agreement could not come at a better time. Understanding the need for more robust patent laws, the Colombian government is aggressively reshaping its IP system. The authors had the opportunity to meet with Jose Luis Londoño Fernández, Superintendent of Industrial Property (Colombias equivalent to the USPTO). He was enthusiastic about the Colombian patent system and the Patent Prosecution Highway and is eagerly seeking to educate Colombians and the global public about the mechanisms available for protecting their ideas and innovations. Mr. Londoño believes so strongly in patent protection that he is in the process of separating the patent office from the trademark and copyright office to allow the patent department to rapidly expand. Mr. Londoños ...
Colombia has reached an agreement with the USPTO to participate in the Patent Prosecution Highway, becoming the first South American country to gain such status. With Colombias sturdy economy and confident move into the global marketplace, this agreement could not come at a better time. Understanding the need for more robust patent laws, the Colombian government is aggressively reshaping its IP system. The authors had the opportunity to meet with Jose Luis Londoño Fernández, Superintendent of Industrial Property (Colombias equivalent to the USPTO). He was enthusiastic about the Colombian patent system and the Patent Prosecution Highway and is eagerly seeking to educate Colombians and the global public about the mechanisms available for protecting their ideas and innovations. Mr. Londoño believes so strongly in patent protection that he is in the process of separating the patent office from the trademark and copyright office to allow the patent department to rapidly expand. Mr. Londoños ...
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 203 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ---------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S., ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMENS HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as Directors of the University of Utah ...
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 63 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S.; ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMENS HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, 09 Civ. 4515 (RWS) ECF Case v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as ...
6 January, 2014 PRV joined the global pilot cooperation on PPH (GPPH) with other Patent Offices. The Pilot concerns both national patent applications and international patent applications (PCT) and replaces the earlier bilateral agreements on PPH that PRV has with the American, Japanese and Korean Patent Offices. The advantage of GPPH compared to the previous bilateral PPH agreements is that GPPH constitutes a common regulatory framework for all the GPPH affiliated Offices, which facilitates administration for applicants who do not have to adapt to different rule systems. PPH means that an applicant, who has filed an application to a PPH Patent Office and received a positive opinion about the patentability of at least one claim in a patent application, may, when filing a corresponding application to another PPH Patent Office, request expedited processing by filing a PPH request. Regulatory framework for GPPH For additional information on the regulatory framework see GPPH Here you will find in
Could it be happening!? All it took was a government shutdown to convince Valve to take what looks to be the next step towards Half-Life 3. As spotted by NeoGAF, Valve has registered Half-Life 3 with Europes trademarks office, the OHIM.. Upon visiting the actual European trademark office website and looking up the trademark (#012180394), you can clearly see its legit. Valve apparently registered for the trademark on September 29, 2013, and its currently listed as Computer game software; Electronic game software; Downloadable computer game software via a global computer network and wireless devices; Video game software.. While the trademark appears to be official, Valves actual motivation remains in question. Is Valve actually taking the next step in developing Half-Life 3 or are they merely trying to protect their IP?. Things certainly just got a whole lot more interesting!. ...
CTPLO - China Trademark & Patent Law Office. Peoples Republic of China. 中华人民共和国国家工商行政管理总局商标局 China Trademark Office (CTMO)
CTPLO - China Trademark & Patent Law Office. Peoples Republic of China. 中华人民共和国国家工商行政管理总局商标局 China Trademark Office (CTMO)
Leaps trading strategies pdf #### UNITED STATES PATENT AND TRADEMARK OFFICE TRADEMARK ELECTRONIC SEARCH SYSTEM Macam mana nak mula forex #### Kerridge motor trade systems
Binary options books amazon #### PATENT AND TRADEMARK OFFICES TRADEMARK ELECTRONIC SEARCH SYSTEM Trading and investment strategies in behavioral finance #### Forex widget
Dear minarah, The U.S. Patent and Trademark Office issued the patent for the antiviral combination of the two active ingredients lamivudine and zidovudine, branded as Combivir, on 12 January 1999. The patent number is 5,859,021. The U.S. trademark Combivir for that drug was applied for by Glaxo Group Limited on 20 February 1997 and registered by the Trademark Office on 19 May 1998. Combivir was launched in the USA on 26 September 1997. Hope this answers your question! Regards, Scriptor Sources: M decins Sans Fronti res: Annexes (PDF file) http://www.accessmed-msf.org/upload/ReportsandPublications/492001113146/Annexes.pdf GalaxoSmithKline: Annual Report - Intellectual Property http://www.gsk.com/financial/reports/ar/report/descrip_of_bus/intell_property/intell_prop.html United States Patent and Trademark Office: Patent Database http://patft.uspto.gov/netahtml/PTO/search-bool.html United States Patent and Trademark Office: Trademark Database ...
We asked Sandra Park, a staff attorney with the ACLU Womens Rights Project and one of the lead attorneys on our legal challenge to Myriad Genetics patents on the "breast cancer genes," to answer a few questions about this landmark case. The case is The Association of Molecular Pathology, et al v. Myriad Genetics and will be heard by the Supreme Court on April 15th. Breast Cancer Action is the only breast cancer organization that is a plaintiff in this case. 1. Why did the ACLU decide to take on a legal challenge to human gene patents?. This is the first patent case ever brought by the ACLU, so we studied the issue closely and consulted with many people before deciding to get involved. Ultimately, we realized that gene patents, and the policy of the U.S. Patent and Trademark Office of granting these patents, must be challenged because of the important civil liberties concerns they raise. Gene patents stand in the way of scientific innovation and medical care because they allow the patent holder ...
Trademark and unfair-competition laws are designed to prevent a competitor from selling goods or services under the auspices of another. Trademark law, not copyright law, protects trademarks, service marks, and trade names. Trademarks are legally registered words, names, symbols, sounds, or colors or any combination of these items that are used to identify and distinguish goods from those goods manufactured and sold by others and to indicate the source or origin of the goods (eg, brand names). Examples of commonly recognized trademarks include Time magazine, NBC, and Coca-Cola. A service mark is the same as a trademark except that it
Trademark and unfair-competition laws are designed to prevent a competitor from selling goods or services under the auspices of another. Trademark law, not copyright law, protects trademarks, service marks, and trade names. Trademarks are legally registered words, names, symbols, sounds, or colors or any combination of these items that are used to identify and distinguish goods from those goods manufactured and sold by others and to indicate the source or origin of the goods (eg, brand names). Examples of commonly recognized trademarks include Time magazine, NBC, and Coca-Cola. A service mark is the same as a trademark except that it
The granting and exercise of patent rights should be consistent with the basic goals and interests of the society, particularly promotion and protection of public health.. • There is no single patent system. While recognizing its international obligations, each country should shape its patent law according to its socio-economic needs and objectives, including in relation to public health.. • Although the TRIPs Agreement imposes various constraints, it leaves considerable room for countries to design their national laws to address public health concerns.. • Developing patent rules to improve access to medicines, particularly by the poor, is an important public health objective.. • The improvement of access to medicines requires a pro-competitive approach in several aspects of patent legislation.. • Such an approach should aim, as a priority objective, to ensure that patents are granted on developments that constitute true technical contributions, and that patent rights are not unduly ...
2017 BTG International Ltd. All rights reserved. "See More, Reach Further, Treat Smarter", "Imagine where we can go", and BTG and the BTG roundel logo are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd in the US, EU and certain other territories. Bead Block, DC Bead, DC Bead LUMI, LC Bead and LC Bead LUMI are trademarks and/or registered trademarks of Biocompatibles UK Ltd. EKOS and EkoSonic are registered trademarks of EKOS Corporation. GALIL is a trademark of Galil Medical Ltd. PneumRx is a registered trademark of PneumRx, Inc. TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd. Varithena is a registered trademark of Provensis Ltd. CroFab and DigiFab are registered trademarks of BTG International Inc. Voraxaze is a registered trademark of Protherics Medicines Development Ltd. Lemtrada is a trademark of Genzyme Corporation. Zytiga is a trademark of Johnson & Johnson. ...
Biologics patent applications typically contain large numbers of sequences and various combinations of sequence segments. The process of compiling and annotating these sequence lists can be time consuming at best, and in the worst case, errors may go unnoticed until after the patent application has been published. In fact, a substantial number of published patent applications contain serious errors. Typical errors include cases in which the CDR or variable domain combinations are not unique and unintentionally claimed redundantly within a patent application or a CDR or variable domain definition are not consistent between the patent application text and the sequence listing. Other typical errors are having individual sequences concatenated instead of listed as separate sequences or listing incorrect sequence variants. Genedata Biologics helps to prevent such serious errors by automatically tracking, annotating, processing, and properly formatting all relevant sequences for patent applications. ...
U.S. Patent Office Grants Patent On QPIs Breakthrough PhotoMotion Multi-Imaging Technology Quik Pix Inc. Buena Park, CA (OTCBB SYMBOL: QPIX) announced today that the Company has been granted the Patent on a breakthrough technology, PhotoMotion Multi-Imaging. QPI is a company specializing in high quality photographic imaging and visual marketing technologies. The Patent just awarded covers the technology enabling QPI to combine three or more images into a single color transparency that, as if by magic, changes as the astonished viewer moves past the image. The image moves with the viewer. The illusion is optical and requires no special equipment or other mechanism to create this mystical effect. PhotoMotion Multi-Imaging Technology images combined with text or graphics readily fit into existing light box fixtures creating a visual presentation that is so amazing and distinct that PhotoMotion stands to revolutionize the imaging for most backlit advertising displays used in tradeshows, point of ...
Downloadable! Economists and policy makers have long recognized that innovators must be able to appropriate a reasonable portion of the social benefits of their innovations if innovation is to be suitably rewarded and encouraged. However, this paper identifies a number of specific fact patterns under which the current U.S. patent system allows patent holders to capture private rewards that exceed their social contributions. Such excessive patentee rewards are socially costly, since they raise the deadweight loss associated with the patent system and discourage innovation by others. Economic efficiency is promoted if rewards to patent holders are aligned with and do not exceed their social contributions. This paper analyzes two major reforms to the patent system designed to spur innovation by better aligning the rewards and contributions of patent holders: establishing an independent invention defense in patent infringement cases, and strengthening the procedures by which patents are re-examined after
In a recent decision dated 26th June, 2018, the Assistant Controller of Patents and Designs exercised his power under Section 15 of the Patents Act, 1970 ("the Act") and rejected the bid for a patent application. Below, I give a brief description of the patent application and the reasons which led the Controller to come to such a decision, before analyzing the final order.. About the Patent Application. The applicant, Bayer Intellectual Property Gmbh (Initially, Bayer Animal Health Gmbh was the applicant and they later assigned their patent rights to the present applicant), had applied for patent application number 9382/DELNP/2010 for a pharmaceutical invention entitled "Use of nifurtimox for treating giardiasis" on 31st December, 2010. A perusal of the abstract, claims and full description reveals that the said application proposed several compositions containing nifurtimox and an anthelmintic (anti-parasitic drug) for treatment of giardiasis (a particularly nasty intestinal infection caused by ...
However, it should be noted that there are exceptions that may justify a trademarks not having been in genuine use for five years following its registration. Section 26(1) of the act provides that, in certain circumstances, the trademark owner can show legitimate cause for not using a trademark. For example, the trademark owner may not use the relevant trademark in relation to pharmaceuticals for which the registration and validation process takes a long time and prevents the product from being placed on the market; or in relation to products which are typically sold only in holiday seasons such as Christmas and Easter. It is self-evident that such products are not sold throughout the year, but rather are sold only in the respective season (yet in large amounts ...
Cinderella is a Walt Disney Character ©Disney. 101 Dalmatians is a Walt Disney Movie ©Disney. Donald Duck is a Walt Disney Character ©Disney. Hello Kitty is a trademark of SANRIO CO. LTD. Mickey Mouse is a Walt Disney Character ©Disney. Shrek is a trademark of DreamWorks SKG. SNOOPY is trademark by PEANUTS WORLDWIDE, LLC. Garfield is a trademark of Paws, Inc. Snow White is a character of © Disney. Spider-Man is a registered trademark of Marvel Characters, Inc.. SpongeBob is a trademark of Nickelodeon. "Superman" is a registered trademark of DC Comics. Toy Story is a registered trademarks of Disney Enterprises, Inc.. Winnie the Pooh and all related characters and elements are trademarks of © Disney. "Dora the Explorer" and characters are a registered trademark of Nickelodeon and Viacom.. THE MR MEN are trademarks of THOIP (a Chorion company). Transformers is a registered trademark of the Hasbro company. Hannah Montana and all related characters and elements belong to © Disney. Teenage ...
You have asked for our legal opinion on the patentability of inventions claimed in U.S. patent applications 07/716,831, filed June 21, 1991 (the 831 application, or .831), 07/837,195, filed September 25, 1992 (195), and 07/952,911, filed February 12, 1993 (.911), all filed in the name of Craig Venter and others and assigned to the National Institutes of Health (NIH). We understand that NIH has abandoned these patent applications and has no present intention of filing similar applications in the future, but that NIH remains interested in the patenting of human DNA sequences from a broader public policy perspective. We have therefore attempted to focus on issues that are likely to recur in other patent applications filed by other people and institutions involved in DNA sequencing rather than on questions that are peculiar to the facts of these particular applications. Nonetheless, we preface this opinion letter with the caution that the facts of each patent case are unique. We have before us for
BPAI Board of Patent Appeals and Interferences Patent and Trademark Office (P.T.O.) *1 DE SOLMS v. SCHOENWALD ET AL. Patent Interference No. 101,698 - IP Mall
RetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No....
As the battle rages over threats to the Internet architecture, a recent publication over the Patent Application for Domain Name Transfers by Verisign is disturbing for those who advocate an open and free Internet. The Application is based on an immediate and direct threat towards an open and free Internet. Just in case people are tempted to think that this was a prank given that they filed it on the 1 April 2011, searches at the United States Patents and Trademark Office (USPTO) reveals that this is a legitimate application .
patents resume This patent resulted from a continuation application of U.S. patent application Ser. No. 10/788,557, filed Feb. Business Report.? 27, 2004 now abandoned; which is a continuation of U.S. Tire Conversion Chart? patent application Ser.. No. 10/437,650 (now U.S. Pat. No. 6,718,345), filed May 13, 2003; which is a continuation of Business Report Example-Of-A U.S. patent application Ser. Sample? No. 10/121,247 (now U.S. Pat. Format Of A Report. Sample Report? No. 6,564,188), filed Apr. Report-Format By Vishal? 10, 2002; which is a continuation of U.S. patent application Ser.. No. Format Of A Business Report. Business? 09/054,339 (now U.S. Pat. No. For Career Change? 6,718,340), filed Apr. 2, 1998; which is a continuation of U.S. patent application Ser. No. 08/597,359 (now U.S. Pat. No. 5,758,324), filed Feb.. 8, 1996; which in Of A Sample Business Example-Of-A, turn claims priority from U.S. Provisional Application Ser. No. 60/008,700, filed Dec. 15, 1995; all of which are incorporated ...
Ah silly patents. Remember back when British Telecom thought that it held a patent on hyperlinks? And then thereve been multiple different patents claiming ownership of the idea of putting an image on a website. Well, it appears that a company in Singapore has recently merged the two ideas into its own patent, and boy, is it ever ready to sue just about everyone. Slashdot points us to the news that Singaporean image search firm Vuestar Technologies claims to hold a patent on linking images from a website to another site and is sending out threatening letters to a bunch of websites. No one has linked to the actual patent so its difficult to see what it really covers -- but the idea that a recent patent would cover the concept of linking images seems preposterous ...
ROCKVILLE, Md., Oct. 31, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it has received a notice of allowance from the United States Patent and Trademark Office for a patent for claims related to the synthesis of its novel anti-cancer...
: Patent Examiner, U.S. Patent and Trademark Office. Aug 2003 - Aug 2008: Graduate Student/Doctoral Candidate, Neuropharmacology, Virginia Commonwealth University - Virginia Medical College. 2000 - 2006: Project Toxicologist, HSW Engineering, Inc.. Aug 1999 - May 2000: Science Instructor, Clearwater Central Catholic High School. 1999 - 1999: Engineering Technician, Florida Department of Transportation. 1995 - 1999: Research Assistant, University of Florida - Department of Environmental Engineering Sciences. 1997 - 1998: Teaching Assistant. 1995 - 1997: Laboratory Assistant, Columbia North Florida Regional Medical Center. - Silver Spring, US-MD
BPAI Board of Patent Appeals and Interferences Patent and Trademark Office (P.T.O.) *1 EX PARTE PATRICK CHUNG-SHU KUNG AND GIDEON GOLDSTEIN Appeal No. 88-0962 - IP Mall
Evidence-Based Complementary and Alternative Medicine (eCAM) is an international peer-reviewed, Open Access journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine.
Freshpatents.com offers information on a variety of new patent applications, updated each week - check out Drug, bio-affecting and body treating compositions inventions February -
As with many gene patents, the gene patent case Association for Molecular Pathology et al. v. USTPO et al. (Myriad) [3] included both method and product claims, which are affected differently by recent court decisions. On 20 March 2012, a unanimous Supreme Court held in Prometheus v. Mayo (Prometheus) [4] that Prometheus Laboratories claims to methods of optimizing the dosage of drugs to treat gastrointestinal autoimmune diseases do not qualify as patentable subject matter under section 101 of the Patent Act (the section that specifically deals with what types of subject matter are eligible for patenting) [5].. Prometheus itself is not a gene patent case but has important implications for gene patents, especially claims of the method type. Thus, shortly thereafter, the Supreme Court issued a GVR order for the Myriad case [3] in light of their decision in Prometheus. A GVR order means that in one swift motion, the Supreme Court (1) granted review of the Myriad case, (2) vacated the ...
SAN RAMON, Calif., April 11, 2016-- SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that the Patent Trial and Appeal Board of the United States Patent and Trademark Office has initiated an inter partes review...
Nonresidents per million: Patent applications are applications filed with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years. Figures expressed per million population for the same year ...
Title: Recent Patents on the Extraction of Carotenoids. VOLUME: 2 ISSUE: 1. Author(s):Ezio Riggi. Affiliation:National Research Council Italy - Institute for Agricultural and Forest Systems in the Mediterranean, Str. le Lancia, Blocco Palma I, Zona Industriale. 95121 - Catania, Italy.. Keywords:Carotenoids, lycopene, β-carotene, extraction, supercritical fluid extraction, patents, waste. Abstract: This article reviews the patents that have been presented during the last decade related to the extraction of carotenoids from various forms of organic matter (fruit, vegetables, animals), with an emphasis on the methods and mechanisms exploited by these technologies, and on technical solutions for the practical problems related to these technologies. I present and classify 29 methods related to the extraction processes (physical, mechanical, chemical, and enzymatic). The large number of processes for extraction by means of supercritical fluids and the growing number of large-scale industrial plants ...
... - Network Solutions has no knowledge of whether any content on this page violates any third party intellectual property rights. Network Solutions will promptly remove any content reasonably objected to by the Owner of a pre-existing trademark. If you have a Trademark issue, please contact [email protected] ...
Not all products and/or indications are available in the US and certain other territories. LC Bead and Bead Block are trademarks and/or registered trademarks of Biocompatibles UK Ltd. EKOS, the EKOS logo, Acoustic Pulse Thrombolysis and EkoSonic are trademarks and/or registered trademarks of EKOS Corporation. TheraSphere® is manufactured for Biocompatibles UK Ltd. TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd. Varithena is a registered trademark of Provensis Ltd. PneumRx and RePneu are trademarks of PneumRx. PneumRx is a registered trademark in the US and certain other territories. The RePneu Coils are not approved for commercial sale in the United States, and are restricted by US law to investigational use only in the U.S. See more. Reach further. Treat smarter and Imagine where we can go are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd. Biocompatibles UK ...
Google says it has evaluated case law surrounding the issues, and is acting to provide users with more choice.. "Its important for us to give the user choices and if the trademark owner is able to make sure that no other ads appear, then that removes user choice," said Rose Hagan, Googles senior trademark counsel. "The users will determine if those ads are relevant or not." In Googles AdWords system, an ads ranking is determined by how much advertisers pay, along with how many clicks the ad gets. The move will also serve to wring as much money as possible from the popular advertising program, given the murky legal status of trademarks in search engine advertising.. "If Google is foregoing substantial revenues, its probably a smart decision provided it does so with the knowledge that it might have problems in the future," said Douglas Wood, an expert on advertising law and a partner with Reed Smith Hall Dickler. Wood says Googles disavowal of responsibility for policing trademarks is ...
Trademark registration for Makers Mark Seal Upheld: On March 26, 2010 a federal judge ordered an injunction which ended a seven year legal battle. The order was entered by U.S. District Judge John G. Heyburn II in the form of...
Title: RNA as a Drug Target: Recent Patents on the Catalytic Activity of Trans- Splicing Ribozymes Derived from Group I Intron RNA. VOLUME: 4 ISSUE: 1. Author(s):Irudayam Maria Johnson. Affiliation:Department of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.. Keywords:Group I intron ribozyme therapy, group I intron splicing inhibitors, trans splicing ribozyme, patents of trans splicing ribozymes, drug targeting, small molecules, self-splicing, catalytic activity, RNA repair, mutant RNA. Abstract: The importance of RNA in vital cellular events like gene expression, transport, self-splicing catalytic activity etc., renders them an alternative target for drugs and other specific RNA binding ligands. RNA targets gain significance for the fact that targeting DNA with therapeutics sooner leads to drug resistance and severe side effects by impairing essential function of the genes. However the unique structural features of the RNA facilitate targeting in two ...
Document Type and Number: United States Patent Application 20160312283. Abstract:. This invention generally relates to lncRNAs and methods for diagnosing cardiac pathologies in a subject. The invention also provides methods for treating a cardiac pathology in a subject comprising administering to said subject an effective amount of a modulator of one or more lncRNAs of the invention.. Inventors: Ounzain, Samir (Lausanne, CH) - Pedrazzini, Thierry (Le Mont-sur-Lausanne, CH ...
The case involved a Shenzhen health care products company called Yelaixiang, which had filed the "百度" (Baidu) trademark in 2005 and received approval in 2008. (Almost three years! Another reminder of the problem of long queues at the Trademark Office, which they have already cut down on substantially.). Is Yelaixiang a trademark squatter? Yes, although some specifics are necessary here. They filed in 2005, long after Baidu was a famous company. Some of Baidus trademark filings go back to 2001. I think it would be difficult to argue that Yelaixiang was not aware of Baidus brand when it filed for protection in 2005 - I call that bad faith and trademark squatting. Assuming all this can be proven, of course.. All right, the next bit of relevant information here requires us to talk about product classification. Remember that when you file for trademark protection, you have to specify which products or services you wish to protect. You cannot simply go to the Trademark Office and ask for ...
You came up with what is in your estimation the next best invention. For the purposes of illustration, lets say your invention is a car that boasts a 0-60 mph time of less than 4.0 seconds. The key to your invention is a V-8 engine combined with a smattering of technical features. You visit with your patent attorney, she drafts and files a patent application, and you are eventually awarded a patent. You got what you wanted, right? A patent is a patent.. Not necessarily. As you may know, a patent is a right to exclude others from making, using, selling, offering to sell, or importing your patented invention for a limited period of time (right now 20 years from the day you file your patent application). In exchange for the right to exclude others, your patent must include a detailed disclosure of how to make, use, or perform the invention. As to what your "invention" is exactly, that is defined by the patent claims. The claims define the "scope" of the invention-essentially the boundary of the ...
It comprises the use of D-fagomine or derivatives thereof in the prevention and/or coadjuvant treatment of bacterial infections, as well as to pharmaceutical, veterinary, or food and feed, pet food compositions containing them.
angry tapir writes Microsoft is asking the US Patent and Trademark Office to deny Apple a trademark on the name App Store, saying the term is generic and competitors should be able to use it. Apple applied for the trademark in 2008 for goods and services including retail store services featuring...
Apple has had two more trademarks added to their ever growing arsenal today. The US Patent and Trademark office granted Apple the trademarks today for the word
Search for Specific Application Of Weight Responsive Control System Patents and Patent Applications (Class 700/305) Filed with the USPTO
New submitter Drishmung writes Retired Judge Paul Michel, who served on the Federal Circuit 1988-2010 — the court that opened the floodgates for software patents with a series of permissive decisions during the 1990s — thinks software patents are good. Yes, the patent system is flawed, ...
Our official company name is "Sitecore Corporation A/S", a Danish company with local wholly owned subsidiaries around the world where we conduct business. We are most often referred to as "Sitecore," as this is both our company name and our trademark for goods and services. Sitecore has obtained valuable rights through proper and continuous use of its trademarks. Adherence to these Guidelines will help to maintain the integrity of our brands and preserve their value.. What is a trademark?. A trademark is a word, name, symbol, device, design or phrase adopted and used by Sitecore to identify its goods and services and to distinguish them from the goods and services of others. Trademarks, otherwise known as brands, are usually marked with either a ™ or an ® symbol (a ™ designates an unregistered trademark and an ® designates a registered trademark). Sitecore owns many different trademarks, some of which are listed below. All rights to Sitecore trademarks are reserved.. Sitecore® and Own the ...
On June 29, 2016, the U.S. Patent and Trademark Office (USPTO) launched a pilot program to provide expedited review of patent applications directed to cancer immunotherapy. Under the new program, a patent application having at least one claim to a method of treating cancer using immunotherapy can be "made special" and advanced out of turn for examination, simply by filing a grantable petition. The program is intended to support the White Houses $1 billion initiative to achieve ten years worth of cancer research in the next five years.. Unlike the USPTOs accelerated examination and Prioritized Examination (Track I) programs, no fees are required to participate in the Cancer Immunotherapy Pilot Program.. To be eligible for the program, a patent application must include at least one claim directed to a method of treating cancer using immunotherapy. According to the USPTO, the claim should encompass "a method of ameliorating, treating, or preventing a malignancy in a human subject wherein the ...
A NASA LENR-related patent application that lists Dr. Joseph Zawodny as Inventor, senior staff physicist at NASA-LaRC, was published by the USPTO on October 2…
Prous Institute for Biomedical Research has announced the recent publishing of its new WIPO patent application. The cited compounds figured among the new magnolol and honokiol derivatives obtained at the Prous Institute for Biomedical Research that have shown inhibitory activity against multiple protein kinases, including epidermal growth factor receptor (EGFR), proto-oncogene tyrosine-protein kinase Src, cyclin-dependent protein kinase (CDK2), protein kinase C (PKC) and mitogen-activated protein kinase (MAPK 1). The compounds antiproliferative activity (IC50 = 0.9-4.6 mcM) has been demonstrated in brain, colon, liver, ovary, prostate and breast tumor cell lines, as well as melanoma and leukemia cell lines. These novel compounds have potential to suppress tumor growth and/or prevent recurrence of metastasis. In vivo efficacy of the compounds has been proven using tumor xenografts models. Furthermore, analgesic activity of claimed compounds has been observed in experimental animal models of pain ...
The Japanese Patent Office has granted the first patent for induced pluripotent stem cells (iPS cells) to Kyoto University, where researcher Shinya Yamanaka produced both the first non-human iPS cells in 2006 and, using the same process, the first human iPS cells in 2007.The Japanese patent, a limited version of a much broader international patent application covering all forms of iPS cell (excluding germ cells) across all species, covers only human iPS cells created using Yamanakas process based on reprogramming adult cells using four gene factors.. The granting of the patent in Japan was fast-tracked by Patent Office officials so as to make clear the Universitys claim while the broader patent goes through lengthy processing across the worlds other major patent institutions. The urgency in part reflects the contemporaneous progress of a US team headed by James Thomson at the University of Wisconsin which published its own successes in producing human iPS cells on the same day as Yamanaka in ...
First American Scientific Corp (FASC.OB) Announces Approval of Patent Application for Recovery of Fuel from biomass by Japanese Ministry of International Economy and Industry
A 2009 continuation patent application claim lacks adequate written description in a 2000-filed specification despite its description of all claim limitations, the U
American Manganese Inc. (TSX.V: AMY; Pink Sheets: AMYZF): PCT International Patent Application Submitted For Lithium Ion Batteries Recycling Process And Recovery Of Cathode Materials
The European Patent Office Enlarged Board of Appeal yesterday gave its decision on the so-called "broccoli" and "tomato" cases, and excluded "essentially biological processes for the production of plans (or animals)" from patentability.. The Board concluded that "while technical devices or means, such as genetic markers, may themselves be patentable inventions, their use does not make an essentially biological process patentable.". Past IPW coverage here (IPW, Biodiversity/Genetic Resources/Biotech, 21 July 2010).. Non-profit organisations the Berne Declaration and Swissaid praised the decision but said that the EPO was still granting patents on selected materials such as genetic sequences, on technical process and on genetically modified plants and animals. The Berne Declaration calls for a total ban on patents on plants, animals, food derived from plants or animals, and selection processes.. Read the EPO press release here. ...
Cannabics files patent application with PCT authorities on methods for testing therapeutic effectiveness of cannabinoids for cancer patients
Trademarked. By: Ashley Czechowski. Donald Trump has trademarked "Success by Trump" cologne, the "Donald J. Trump Signature Collection" for luggage and shoe-shine kits, and he even held one for "Trump Steaks" until 2014. And John Oliver, well-known comedian is trying to trademark "Drumpf.". Oliver claims "Drumf" is Donald Trumps ancestral family name and he has created the donaldjdrumpf.com website where he sells the "Make Donald Drumpf Again" hats, which are on backorder. It also offers a Chrome browser extension to replace all instances of the word "Trump" with "Drumpf" in a news feed.. Oliver filed a trademark application February 26, 2016 for "Drumpf," and given the processing time of trademarks at the U.S. Patent and Trademark Office, it may take up to four to five months before a preliminary decision is issued. The trademark application was filed by Howard Shire, a partner at Kenyon & Kenyon in New York.. It should be noted that if Trump seeks to object to trademark registration, he may ...
Trademarked. By: Ashley Czechowski. Donald Trump has trademarked "Success by Trump" cologne, the "Donald J. Trump Signature Collection" for luggage and shoe-shine kits, and he even held one for "Trump Steaks" until 2014. And John Oliver, well-known comedian is trying to trademark "Drumpf.". Oliver claims "Drumf" is Donald Trumps ancestral family name and he has created the donaldjdrumpf.com website where he sells the "Make Donald Drumpf Again" hats, which are on backorder. It also offers a Chrome browser extension to replace all instances of the word "Trump" with "Drumpf" in a news feed.. Oliver filed a trademark application February 26, 2016 for "Drumpf," and given the processing time of trademarks at the U.S. Patent and Trademark Office, it may take up to four to five months before a preliminary decision is issued. The trademark application was filed by Howard Shire, a partner at Kenyon & Kenyon in New York.. It should be noted that if Trump seeks to object to trademark registration, he may ...
Health,... PITTSBURGH Jan. 12 /- Mylan Inc. (Nasdaq: ... U.S. Patent No. 7462645 was issued Dec. 9 2008 and is directed... U.S. Patent Nos. 7465756 and 7473710 were issued Dec. 16 2008... In addition Dey has received a Notice of Allowance on yet anoth...,U.S.,Patent,and,Trademark,Office,Issues,Mylans,Specialty,Division,,Dey,L.P.,,Three,Additional,Patents,Protecting,Perforomist(R),Inhalation,Solution,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
GenSpera Receives Patent on Targeted Prostate Cancer Drugs SAN ANTONIO--(BUSINESS WIRE)-- GenSpera, Inc. (OTC.BB: GNSZ) announced that the United States Patent and Trademark Office (USPTO)
November 29/New Delhi, India/Indian Patents News -- Norway based Pharmalogica AS filed patent application for drink formula comprising fresh marine omega-3 oil and antioxidants. The inventors are Mathisen Janne Sande and Mathisen Henrik. Pharmalogica AS filed the patent application on September 22, 2010. The patent application number is 3507/KOLNP/2010 A. The international classification number is A23L 2/52. According to the controller general of Patents, Designs & Trade Marks, "The present invention relates a new drink formula comprising fresh marine omega-3 oil in an emulsion and . . .
Discover FL FASH LAW CECA MAGAN. Data and details about the registered trademark. Patents and trademarks: your reference website on trademarks, patents and designs. This application has been made by CECA MAGAN ABOGADOS, SLP
TEVA is a trademark and brand of TEVA Pharmaceutical Industries Limited. Filed to USPTO On Tuesday, February 23, 2016, The TEVA covers Printed publications, namely, books, hand-outs, workbooks, and journals, featuring information regarding allergies, the treatment thereof, and patient services for allergies. Search for other trademarks at Trademarkia.
LUXMODREL is a trademark and brand of SUN PHARMACEUTICAL INDUSTRIES LIMITED. Filed to USPTO On Friday, July 1, 2016, The LUXMODREL covers Pharmaceutical preparations for use in dermatology. Search for other trademarks at Trademarkia.
FR of Doc No: 2012-31594] -----------------------. DEPARTMENT OF COMMERCE. United States patent and Trademark office. [Dock No. PTO-P-2012-0052]. Request for Comments and Notice of Roundtable events for Partner-hip for Enhancement of Quality of Software-Related of patent. AGENCY: United States patent and Trademark office, Commerce.. ACTION: Request for comments. Notice of meetings.. ----------------------------. SUMMARY:. The United States patent and Trademark office (USPTO) seeks to form a partner-hip with the software community to enhance the quality of software related of patent (software Partner-hip). Members of the publicly ares invited to participate. The software wants Partner-hip Be in opportunity to bring stakeholders together through a series of roundtable discussions to share ideas, feedback, experiences, and insights on software related of patent. To commence the software Partner-hip and to provide increased opportunities for all to participate, the USPTO is sponsorship two ...
patentpundit writes On April 18, 2008, Apple Computer applied for a patent relating to an invention that allows for showing advertisements within an operating system. The first named inventor on the patent application is none other than Steve Jobs. The patent application published and became avai...
Most patents covering dermatologic products contain patent claims directed to the pharmaceutical formulation of the product. Such patents, known as formulation patents, are vulnerable to attacks based on the legal argument that the formulations covered are obvious over formulations already known prior to the filing of the patent application. Because obviousness is an important concept in patent law, recent court cases concerning obviousness and formulation patents were examined and discussed below. Courts have ruled that patent claims are obvious when features of the claimed formulation are found in the prior art, even if the features or characteristics of the formulation are not explicitly disclosed in the prior art. However, patentees have successfully overcome obviousness challenges where there were unexpected results or properties and/or the prior art taught away from the claimed invention.
Trademark License Agreement - Motorola Trademark Holdings LLC, Motorola Inc. and Motorola Solutions Inc. and Other Business Contracts, Forms and Agreeements. Competitive Intelligence for Investors.
By Richard Stobbe. Inventors must take care that their invention is "new" for it to be patentable. That means the invention hasnt been disclosed to the public. Trade show announcements, press releases, publications, offering the invention for sale - all of these can be considered a public disclosure, and if disclosure of the invention occurs before the date of filing of the patent application, this disclosure could defeat patentability, since the invention is no longer "new" for patenting purposes.. In Canada and the U.S. there is a 12-month grace period, so the date of prior disclosure is measured against this 12-month period: put another way, patentability may be lost if the invention was disclosed by the inventor more than one year before the filing date of the patent.. So how does this apply to experimental use? How can an inventor test new inventions and avoid the problems associated with public disclosure?. The recent decision in Bombardier Recreational Products Inc. v. Arctic Cat Inc. is ...
Should you file a provisional patent application? Although Patwrite is a full service Intellectual Property Law Firm with corporate clients, we specialize in helping private inventors get legal protection for their intellectual property. Because of this, we hear this question on a daily basis. Most clients want us to tell them what they should do. We really cant make the decision for you, but we can give you the information you need to make an informed decision. First lets look at the history of the provisional patent and just exactly what it is. The provisional patent application (PPA) is a fairly new innovation in the US patent system. It has only been around for about 10 years. Part of the problem that the PPA addresses, is that the US awards patents to the first to invent rather than the first to file used by the rest of the world. It is beyond the scope of this paper to get involved in that debate, but the need to quickly establish a priority date is needed and the provisional ...
A brief review of all of the articles Ive written in these here pages about sweet, delicious alcohol mostly have to do with trademark spats between drink-makers, including many in which Ive made the point that its high time for the USPTO to get a little more subtle when it comes to its alcohol marketplace designations. Beer isnt wine, and wine isnt liquor, and the public looking to buy one of those is quite unlikely to confuse one product for another. The focus of many of those posts was how this lack of distinction between the alcohol markets has resulted in too many aggressive trademark lawsuits and threat letters that hardly seemed necessary. But there is a flip side to all of this that serves as another perfectly good reason for the USPTO to make a change. Recently, one liquor distiller sued another in what seems like a fairly plausible trademark infringement case. ...
Machinery China, Shoes Silicone Trademarks Heating Pressing Machine, The shoes Silicone Trademarks Heating Pressing Machine is for producing the silicone Trademarks on shoes and leather, al...
BD In-Fusion™ is a trademark of BD Biosciences Clontech; Gateway® is a registered trademark of Invitrogen Life Technologies; LNA™ and Locked Nucleic Acid are trademarks of Exiqon; NASBA® is a registered trademark of bioMerieux; SYBR® is a registered trademark of Molecular Probes, Inc.; TaqMan® is a registered trademark of Roche Molecular Systems, Inc.; TOPO® is a registered trademark of Invitrogen Corporation; MLPA® is a registered trademark of MRC-Holland ...
American trademark law has long operated on the assumption that there exists an inexhaustible supply of unclaimed trademarks that are at least as competitively effective as those already claimed. This core empirical assumption underpins nearly every aspect of trademark law and policy. This Article presents empirical evidence showing that this conventional wisdom is wrong. The supply of competitively effective trademarks is, in fact, exhaustible and has already reached severe levels of what we term trademark depletion and trademark congestion. * * * These data show that rates of word-mark depletion and congestion are increasing and have reached chronic levels, particularly in certain important economic sectors. The data further show that new trademark applicants are increasingly being forced to resort to second-best, less competitively effective marks. Yet registration refusal rates continue to rise. The result is that the ecology of the trademark system is breaking down, with mounting barriers ...
GNU may be a registered trademark of the Free Software Foundation. Linux is a registered trademark of Linus Torvalds. Ubuntu and Canonical are registered trademarks of Canonical Ltd. Debian is a registered trademark of Software in the Public Interest, Inc. And of course Intel is a registered trademark of Intel Corporation, and AMD is a registered trademark of Advanced Micro Devices, Inc. Windows, XP, Vista, Windows 7 and Microsoft Office are registered trademarks of Microsoft Corporation. My research shows that "embrace, extend and extinguish" is not held as a legal trademark by anyone as of yet. Microsoft might want to snatch that up just to round out their portfolio. Hey, Im just sayin... while I am at it, this is a known spammers email address and I am placing it here so his email address will be harvested by other spammers. [email protected] ...
GNU may be a registered trademark of the Free Software Foundation. Linux is a registered trademark of Linus Torvalds. Ubuntu and Canonical are registered trademarks of Canonical Ltd. Debian is a registered trademark of Software in the Public Interest, Inc. And of course Intel is a registered trademark of Intel Corporation, and AMD is a registered trademark of Advanced Micro Devices, Inc. Windows, XP, Vista, Windows 7 and Microsoft Office are registered trademarks of Microsoft Corporation. My research shows that "embrace, extend and extinguish" is not held as a legal trademark by anyone as of yet. Microsoft might want to snatch that up just to round out their portfolio. Hey, Im just sayin... while I am at it, this is a known spammers email address and I am placing it here so his email address will be harvested by other spammers. [email protected] ...
One of the underlying principals and purposes of trademark law is to avoid confusion among the consuming public. Thus, the principal standard applied when there is a conflict between two trademarks (whether in a lawsuit for trademark infringement, in an opposition proceeding, etc.) is whether there is a likelihood of confusion between the two marks - that is, whether consumers are going to be confused.. ...
Singulair was covered by U.S. Patent No. 5,565,473[17] which expired on August 3, 2012.[18] The same day, the FDA approved several generic versions of montelukast.[19] The United States Patent and Trademark Office launched a reexamination of the patent covering Singulair on May 28, 2009. The decision was driven by the discovery of references that were not included in the original patent application process. The references were submitted through Article One Partners, an online research community focused on finding literature relating to existing patents. The references included a scientific article produced by a Merck employee on the active ingredient in Singulair. A previously filed patent had been submitted in the same technology area.[20] Seven months later the U.S. Patent and Trademark Office determined that the patent in question was valid based on the initial reexamination and new information provided, submitting their decision on December 17, 2009.[21] ...
Geneva, June 2003 Taking forward the review of article .3(b) of the TRIPs Agreement. Joint Communication from the African Group. Council for Trade-Related Aspects of Intellectual Property Rights. Document IP/C/W/404 26 June 2003 (03-3410). Full text [This link may may not display the document on the first try. If this happens, leave your browser open and click this link again] The following is the text of a communication received from the Permanent Mission of Morocco on behalf of the African Group, which was circulated as an advance copy for the Councils meeting on 4-5 June 2003. This communication from the African Group aims to assist in finalising the longstanding issues relating to the review of provisions of Article .3(b) of the TRIPS Agreement. To this end, the communication first indicates the solutions that the African Group considers need to be found; second, it sets out possible areas of agreement on issues that have arisen; third, it provides suggestions on how to resolve issues that ...
As you may know, one of the most usual problems in Mexico in connection to patents on medicines has been the lack of communication between the Mexican Patent and Trademark Office (MPTO) and the Ministry of Health (MH). The MH has authority to approve the manufacture, commercialization and importation of medicines in Mexico. No pharmaceutical product can be sold in Mexico without the approval of the MH. In many cases, the MH has authorized products that infringe Mexican patents. For years the MH argued that patent matters were completely out of its jurisdiction, and if there were patent infringement problems, they should be addressed to the MPTO or the courts. This circumstance created a contradictory situation, where a federal government agency such as the MPTO was issuing patents on medicines, granting to the patentee the exclusive right to the use of the invention in Mexico, while the MH was authorizing the commercialization of products that may infringe a patent on a medicine. On September ...
Trademark applications filed are applications to register a trademark with a national or regional Intellectual Property (IP) office. A trademark is a distinctive sign which identifies certain goods or services as those produced or provided by a specific person or enterprise. A trademark provides protection to the owner of the mark by ensuring the exclusive right to use it to identify goods or services, or to authorize another to use it in return for payment. The period of protection varies, but a trademark can be renewed indefinitely beyond the time limit on payment of additional fees.This page has the latest values, historical data, forecasts, charts, statistics, an economic calendar and news for Trademark applications - total in Netherlands Antilles.
Standardization and Intellectual Property Rights: Conflicts Between Innovation and Diffusion in New Telecommunications Systems: 10.4018/978-1-878289-70-4.ch006: In todays environment of rapidly evolving information and communication technologies (ICTs), technical standardization is said to be confronted by a
Psimei, a recently launched biotechnology company in Middlesex, England, has acquired the license to commercialize the new boron compounds from Brookhaven Science Associates (BSA), the organization that manages Brookhaven for the U.S. Department of Energy. BSA holds U.S. patents and U.S. patent applications covering these compounds and has filed international patent applications, which are pending.. Brookhaven researchers recently performed clinical trials to determine the safety and toxicity limits of an experimental therapy known as boron neutron capture therapy (BNCT) when used with a boronated amino acid called BPA in patients with an incurable brain cancer known as glioblastoma multiforme. In these trials, BNCT was no more effective than conventional therapies in slowing the recurrence of brain tumors.. Compared to BPA, the new boron compounds are expected to deliver higher concentrations of boron to certain tumors than to normal surrounding tissues within the neutron-irradiated regions, ...
This website and it contents are owned by Alex Templeton. The website, its design and its content including each and every photograph are protected by copyright and trademark law and other related intellectual property rights. Copyright in the photographs is owned by Alex Templeton. Alex Templeton photographs are also protected by moral rights. Alex Templeton asserts his moral right to be identified as the author wherever and whenever his photographs are copied or distributed by any means ...
The present invention relates to microfluidic systems, including valves and pumps for microfluidic systems. The valves of the invention include check valves such as diaphragm valves and flap valves. Other valves of the invention include one-use valves. The pumps of the present invention include a reservoir and at least two check valves. The reservoir may be of variable volume. The present invention also relates to a flexible microfluidic system. The present invention additionally relates to a method of making microfluidic systems including those of the present invention. The method includes forming a microfluidic system on a master, connecting a support to the microfluidic system and removing the microfluidic system from the master. The support may remain connected to the microfluidic system or the microfluidic system may be transferred to another substrate. The present invention further relates to a method of manipulating a flow of a fluid in a microfluidic system. This method includes initiating fluid
On June 3, the U.S. Supreme Court agreed to take on the question of whether states (and instruments of the state) are immune from copyright infringement liability under the doctrine of sovereign immunity.1. It is well established that under the Eleventh Amendment that neither states nor instrumentalities of the state may be sued in federal court unless the state or instrumentality waives its sovereign immunity or Congress enacts a law to override it. Congress attempted to do the latter when it passed the Copyright Remedy Clarification Act of 1990 (CRCA). However, nearly every court that has considered the issue since has concluded that the CRCA is unconstitutional.2. The courts have found Congress did not have the constitutional authority to enact the CRCA for two reasons. First, although it is possible to abrogate sovereign immunity through Section Five of the Fourteenth Amendment, which authorizes Congress to protect property rights (including intellectual property rights) from state ...
The present invention provides isolated peptides of the major protein allergens of the genus Dermatophagoides. Peptides within the scope of the invention comprises at least one T cell epitope, or preferably at least two T cell epitopes of a protein allergen selected from the allergens Der p I, Der p II, Der f I, or Der f II. The invention also pertains to modified peptides having similar or enhanced therapeutic properties as the corresponding, naturally-occurring allergen or portion thereof, but having reduced side effects. The invention further provides nucleic acid sequences coding for peptides of the invention. Methods of treatment or of diagnosis of sensitivity to house dust mites in an individual and therapeutic compositions comprising one or more peptides of the invention are also provided.
Summary of Facts and Submissions. I. European patent application No. 00 936 887.9 (publication No. WO 00/76557) was refused by a decision of the examining division of 29 August 2005 on the basis of Article 97 EPC on the grounds of lack of inventive step under Article 56 EPC.. II. The following documents were inter alia cited during the proceedings before the examining division and the board of appeal:. (1) J.-L.A. Shih and R.M. Brugger: Neutron induced brachytherapy: A combination of neutron capture therapy and brachytherapy Medical Physics, vol. 19, no. 2, March/April 1992, pages 369-375. (2) EP-A-0 857 470. (3) US-A-5 840 009. (4) US-A-5 947 889. (4a) DE-A-196 00 669. III. The decision was based on claims 1-19 of the main request filed with letter dated 15 January 2002 (entry into the European phase).. Independent claims 1 of the main request before the examining division read as follows:. 1. A stent for neutron capture therapy, the stent comprising a body portion fabricated from a material ...
May 16, 1967 Filed July 13, 1964 BLOOD PRESSURE MONITORS S. B. LONDON F/G. I AMPLIFIER BLEEDER IGURM CUFF) 3 sheets-sheet 1 N O K10 QOUDOCOQUoOa 24(MAN0METER) M (SIGNAL LAMP) ATTORNEYS May 16, 1967 s. a L @NDON 3,39,623 BLOOD PRESSURE MONITORS Filed July 13, 1964 3 Sheets-Sheet 2 QGVDSSS AMPLIFIER 3s K49KBM6VDCM GV- OCS i6( AHM 36 (MICROPHONE) novAc5 PUMP INVENTOR SEYMOUR B. LONDON F/G. 2 www (v3/Sgam ATTORNEYS May 16, 1967 s. B. LONDON 3,319,623 BLOOD PRESSURE MoNToRs 3 Sheets-Sheet 5 Filed July 1s, 1964 AMPLIFIER 38 swzosvocss SWZOGVDCSG swzaevocs? INVENTOR SEYMOUR B. LONDON United States Patent O 3,319,623 BLOOD PRESSURE MONITORS Seymour B. London, 35 E. Dilido Drive, Dilido Ave., Miami, Fla. 33139 1 Filed July 13, 1964, Ser. No. 382,255 13 Claims. (Cl. 12S-2.05) The present application relates to blood pressure monitors and in particular to mercury column manometer and aneroid manometer monitors for determining and Visually presenting systolic and diastolic blood pressure readings, and in a ...

Cooking For Engineers :: View topic - Patent Pending?Cooking For Engineers :: View topic - 'Patent Pending'?

You can post new topics in this forum. You can reply to topics in this forum. You cannot edit your posts in this forum. You ... If the patent is granted in the future, and if I decide to use the patent to make some money, I have decided that I would ... If the patent is granted in the future, and if I decide to use the patent to make some money, I have decided that I would ... Data formats should never be patented.. Agreed. If the patent is granted then Ill honestly stop visiting and suggesting to ...
more infohttp://www.cookingforengineers.com/forums/viewtopic.php?p=4381

Related eBooks ::: Recent Patents and Topics on Imaging (Discontinued)Related eBooks ::: Recent Patents and Topics on Imaging (Discontinued)

Recent Patents and Topics on Imaging (Discontinued). Formerly: Recent Patents on Medical Imaging. Volume 5, 2 Issues, 2015. ... Current Topics on Fetal 3D/4D Ultrasound. eISBN: 978-1-60805-019-2. ISBN: 978-1-60805-660-6. Edited by: Toshiyuki Hata DOI: ... Current Topics on Fetal 3D/4D Ultrasound. eISBN: 978-1-60805-019-2. ISBN: 978-1-60805-660-6. Edited by: Toshiyuki Hata DOI: ... Topics in Anti-Cancer Research. eISBN: 978-1-60805-478-7. ISBN: 978-1-60805-612-5. Edited by: Atta-ur-Rahman / Khurshid Zaman ...
more infohttps://benthamscience.com/journals/recent-patents-and-topics-on-imaging/related-ebooks/

Most Accessed Articles ::: Recent Patents and Topics on Imaging (Discontinued)Most Accessed Articles ::: Recent Patents and Topics on Imaging (Discontinued)

Recent Patents and Topics on Imaging (Discontinued). Formerly: Recent Patents on Medical Imaging. Volume 5, 2 Issues, 2015. ... Patent Selections:. , 2015; 5(1): 53-57.. DOI: 10.2174/245182710501151228124904. View Abstract Permissions Order Reprints Order ... Pedunculopontine Nucleus Stimulation in Intractable Epilepsy: A Recent Patent on Deep Brain Stimulation Therapy. , 2015; 5(1): ...
more infohttps://benthamscience.com/journals/recent-patents-and-topics-on-imaging/most-accessed-articles/

Patent US5815830 - Automatic generation of hypertext links to multimedia topic objects - Google PatentsPatent US5815830 - Automatic generation of hypertext links to multimedia topic objects - Google Patents

The textual data objects are string-correlated to the topic objects to determine which topic objects are referenced in each ... having a unique topic name embedded, is concatenated and matched with the topic names. In the case of no match, one word is ... The string-correlation is performed in a buffer in which each portion of text relating to a particular topic, ... Topic objects are stored with textual data objects containing references to other topic objects. ...
more infohttp://www.google.com/patents/US5815830?dq=5,241,671

Star Wars Darth Vader  Patent Dome BagStar Wars Darth Vader Patent Dome Bag

Black patent bag from ,i,Star Wars,/i, with embossed Darth Vader inspired design.,br,Interior includes zip pocket and cell ... HOT TOPIC FASHION. New Arrivals Dresses Tops Hoodies & Sweaters Outerwear Bottoms Doctor Who Collection Loki Collection 90s ... Copyright Hot Topic © All Rights Reserved. If you are using a screen reader and are having problems using this website, please ... Black patent bag from Star Wars with embossed Darth Vader inspired design.. Interior includes zip pocket and cell phone & stash ...
more infohttp://www.hottopic.com/product/star-wars-darth-vader--patent-dome-bag/10313758.html

Topic 4 - WIPOs Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing)Topic 4 - WIPO's Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing)

Topic 4 - WIPOs Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing). Lutz ... Topic 4 - WIPOs Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing). Document ... Mailänder, Head, Patent Information Section, Access to Information and Knowledge Division, WIPO, Geneva. ...
more infohttp://www.wipo.int/meetings/en/doc_details.jsp?doc_id=248243

WHO HQ Library catalog ›

    Results of search for su:{Patents as topic}WHO HQ Library catalog › Results of search for 'su:{Patents as topic}'

Patenting of life forms / edited by David W. Plant, Neils J. Reimers, Norton D. Zinder.. by Plant, David W 1931- , Reimers, ...
more infohttps://kohahq.searo.who.int/cgi-bin/koha/opac-search.pl?q=su:%7BPatents%20as%20topic%7D

US20090094233A1 - Modeling Topics Using Statistical Distributions 
        - Google PatentsUS20090094233A1 - Modeling Topics Using Statistical Distributions - Google Patents

A topic is modeled using the statistical distribution generated for the cluster corresponding to the topic. ... The documents are clustered according to the keywords to yield clusters, where each cluster corresponds to a topic. A ... In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are ... Connect public, paid and private patent data with Google Patents Public Datasets Modeling Topics Using Statistical ...
more infohttps://patents.google.com/patent/US20090094233

US9241015B1 - System and method for suggesting discussion topics in a social network 
        - Google PatentsUS9241015B1 - System and method for suggesting discussion topics in a social network - Google Patents

A system and method for suggesting discussion topics in a social network is provided. The method may include identifying a ... US9241015B1 - System and method for suggesting discussion topics in a social network - Google Patents. System and method for ... Accordingly, discussion topic suggestion process 10 may be used to create a list of potential topics for discussion. In some ... Example Discussion Topic Suggestion Processes:. As discussed above and referring also to FIGS. 3-5. , discussion topic ...
more infohttps://patents.google.com/patent/US9241015B1/en

PPT - Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 PowerPoint presentation | free to...PPT - Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 PowerPoint presentation | free to...

Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648. 1. Topics in Viral Immunology Bruce Campell ... PATENTS & TRADEMARKS- Law Office of Sam Sokhansanj - A Patent lawyer is realy useful to: File a Patent Application File for a ... Patent Landscape , Technology Scouting - Best of the implicit statements in the patent law is referred to as a patent landscape ... Patenting Wireless Technology: Infringement and Invalidity - What are B s options? 3 Patent Infringement Defense: Patent ...
more infohttps://www.powershow.com/view4/6ad1e1-NjUzZ/Topics_in_Viral_Immunology_Bruce_Campell_Supervisory_Patent_Examiner_Art_Unit_1648_powerpoint_ppt_presentation

Patented Hops - page 1 - Ingredients - Homebrewers Association | AHA ForumPatented Hops - page 1 - Ingredients - Homebrewers Association | AHA Forum

2) How long are the patents good for?. 3) What happens when the patents expire?. 4) Cascade hops are not patented, did they use ... Here is a plant patent definition from the patent office, first two questions answered:. A plant patent is granted by the ... I found the amarillo patent. I searched the US Patent Office for VGXP01. As in Amarillo® VGXP01 c.v.. However, all I am getting ... If they are actually patented, I would think that you could search for the actual patent. I will do this next and report back. ...
more infohttps://www.homebrewersassociation.org/forum/index.php?topic=5251.msg61841

Answers - The Most Trusted Place for Answering Lifes QuestionsAnswers - The Most Trusted Place for Answering Life's Questions

Contact a patent practitioner (patent agent or patent attorney) for assistance. The United States Patent and Trademark Office ... The patent specification is filed at patent office to obtain patent application number, and patent application will be ... What is a patent-? The official definition for the word patent is "obtain a patent for (an invention)." ... You may wonder "What is patent pending" on a device you purchased, or "How do you obtain a patent?", or "Are patents valuable ...
more infohttp://www.answers.com/topic/patent

Download Absent Fathers 1999Download Absent Fathers 1999

Registered US Patent topic; Trademark Office. development protocol: Juan-Luis Ramos, Roger C. The enough three identities of ... 1) The error of future topics. The Tied download inequalities with environment correlation loyalty and is you well are your ... CFT) difference, not Tracking up presented synchronization downside to audio topic products in higher women. These informers ...
more infohttp://www.altadenaguild.org/test/engine1/book/download-Absent-Fathers-1999/

Intellectual Property: a powerful tool to develop biotech research.Intellectual Property: a powerful tool to develop biotech research.

Patents as Topic*. Research / economics, legislation & jurisprudence*. From MEDLINE®/PubMed®, a database of the U.S. National ... The patent system The worlds first patent procedure was developed in the early Republic of Venice. The first actual patent of ... The evaluation of a patent depends on several parameters, like the age of the patent (to remember that a patent expires 20 ... What is a patent, actually From a juridical point of view, as can be understood from the above, a patent is a juridical ...
more infohttp://www.biomedsearch.com/nih/Intellectual-Property-powerful-tool-to/21255349.html

Recent patents for sodium reduction in foods.Recent patents for sodium reduction in foods.

Patents as Topic. Sodium Chloride, Dietary / metabolism*. Chemical. Reg. No./Substance: 0/Sodium Chloride, Dietary ... Title: Recent patents on food, nutrition & agriculture Volume: 1 ISSN: 1876-1429 ISO Abbreviation: Recent Pat Food Nutr Agric ... There is a clear increasing trend in the number of patents towards a lower salt content in foods as demanded by consumers and ... The recent patents for sodium reductions and its applications in foods are reviewed in this manuscript.. ...
more infohttp://www.biomedsearch.com/nih/Recent-patents-sodium-reduction-in/20653529.html

Natalie M. Derzko  | Covington & Burling LLPNatalie M. Derzko | Covington & Burling LLP

Hot Topics in Patent Law Presentation and Speech October 2008, Patent Resources Group, Albuquerque, New Mexico ... patent litigation, intellectual property policy and law reform. She procures patents and counsels clients on patent matters in ... Strategic patent prosecution advice and representation of various life sciences companies before the U.S. Patent and Trademark ... Expert witness in Hatch-Waxman case on Orange Book patent listing and patent term extension issues and general advice to varied ...
more infohttps://www.cov.com/en/professionals/d/natalie-derzko

An Introduction to Genes and Patents  (May 10, 1995)An Introduction to Genes and Patents (May 10, 1995)

Patents as Topic Genes Ethics Exhibit Category: The Science Administrator as Advocate Relation:. Letter from Jaydee Hanson and ... If the patent is granted, it is good for 17 years. Once a patent is granted, all documents relating to it become available for ... Congressional grants of patents and copyrights are based on Article I, Section 8 of the Constitution. A patent is the grant of ... In 1991 the Patent and Trademark Office granted patent rights to a California company for commercial ownership of human bone ...
more infohttps://profiles.nlm.nih.gov/ps/retrieve/ResourceMetadata/DJBBMY

EZH2 inhibitors: a patent review (2014-2016). - NextBio articleEZH2 inhibitors: a patent review (2014-2016). - NextBio article

Patents as Topic Substances Antineoplastic Agents EZH2 protein, human Enhancer of Zeste Homolog 2 Protein ... EZH2 inhibitors: a patent review (2014-2016). Expert opinion on therapeutic patents. 2017 Jul;27(7):797-813 ... EZH2 inhibitors: a patent review (2014-2016). Giulia Stazi, Clemens Zwergel, Antonello Mai, Sergio Valente ... Areas covered: This review summarizes recent efforts in the drug development of EZH2 inhibitors reported in the patent ...
more infohttp://www.nextbio.com/b/search/article.nb?id=28394193

links - soleilmavislinks - soleilmavis

4) Mind Control Patents. http://peacepink.ning.com/forum/topics/mind-control-patents. (5) Mind Control News articles. http:// ... 2) V2K (voice to skull), in 2002, the Air Force Research Laboratory patented precisely such a technology: Nonleghal weapon ... http://peacepink.ning.com/forum/topics/introduce-v2k-voice-to-skull. (3) Mind Control Weapons. Many victims are suffering from ... http://peacepink.ning.com/forum/topics/information-about-mind-reading. MRI lie detection has been in use. http://peacepink.ning ...
more infohttps://sites.google.com/site/soleilmavis/links

IP Osgoode  » Recent IP PublicationsIP Osgoode » Recent IP Publications

Patents Course Topic (30) *Privacy (237) *Electronic Databases (49) *Human Rights Issues (39) ... "Clerical Errors in the Patent Office" (2011) 23 IPJ 131.. "Consent or No Consent: The Burden of Proof in Intellectual Property ... Global Biopiracy: Patents, Plants and Indigenous Knowledge, (Vancouver: UBC Press, 2006). Collective Insecurity: The Liberian ... Lou on Apotex Successfully Invalidates Patent on Nexium. *Cameron D McMaster on As Netflix Goes Global, CanCon Must Broaden Its ...
more infohttp://www.iposgoode.ca/recent-publications/

Global Health Challenges and the Role of LawGlobal Health Challenges and the Role of Law

Patents Course Topic (30) *Privacy (237) *Electronic Databases (49) *Human Rights Issues (39) ... Lou on Apotex Successfully Invalidates Patent on Nexium. *Cameron D McMaster on As Netflix Goes Global, CanCon Must Broaden Its ... yuriko59 on Book Review - Intellectual Property Law: Copyright, Patents, Trade-Marks, 2nd Ed. ... drug development to address health needs faced by developing and middle income nations under the current international patent ...
more infohttps://www.iposgoode.ca/2012/05/global-health-challenges-and-the-role-of-law/

Unifi Nootropics From the Lab to the Web: A Story of Academic (And Industrial) Shortcomings - PubMedUnifi Nootropics From the Lab to the Web: A Story of Academic (And Industrial) Shortcomings - PubMed

Unifiram and Sunifiram that for a variety of reasons were not protected by a patent. Some 12 years … ... Patents as Topic Actions. * Search in PubMed * Search in MeSH * Add to Search ... Unifiram and Sunifiram that for a variety of reasons were not protected by a patent. Some 12 years after their disclosure (2000 ...
more infohttps://pubmed.ncbi.nlm.nih.gov/25831025/

STN International: DWPI User Guides: Polymer IndexingSTN International: DWPI User Guides: Polymer Indexing

With STN, find precisely the patent and sci-tech information needed to make business-critic ... Patents*. 398167945--.1:6: STN QRC: Patent-specific topics. *. 398164535--.2:6: Multi-File Resources ... New legal status codes for US patent applications and granted patents in INPADOC. Read more ... EPOPIC 2019 - EPO Patent Information Conference, 29.-30. Oct, Bukarest. IP-Service World, 25.-26. Nov, Munich ...
more infohttp://www.stn-international.de/stn_dwpi_ug_polymer_indexing.html

Ross R. Barton | Intellectual Property Litigation Lawyer | Alston & BirdRoss R. Barton | Intellectual Property Litigation Lawyer | Alston & Bird

Ross also frequently updates his clients on hot topic patent issues in the Federal Circuit. ... Represented defendant Nokia in defense of patent infringement claims of nine patents relating to speech coding and GSM ... He previously taught patent litigation courses as an Adjunct Professor at the University of Virginia School of Law and at the ... Ross Barton is a trial lawyer focusing his practice on the litigation of complex patent disputes before district courts and the ...
more infohttps://www.alston.com/en/professionals/b/barton-ross-r
  • In fact, a patent is not an exclusive right to anything at all, but rather the right to exclude OTHERS from making,copyingusing,selling (or offering to sell), orimportingany infringing articles or processes, from the time the patent is published to the time it lapses. (answers.com)
  • In other words, just because you may have a patent, it does not give you any particular right to carry out your own invention, especially if portions of your invention were patented by others. (answers.com)
  • Patenting of life forms / edited by David W. Plant, Neils J. Reimers, Norton D. Zinder. (who.int)
  • There is a common misconception that a patent is "A government grant that gives the holder exclusive rights to a process, design, plant or new invention for a designated perio … d of time. (answers.com)
  • The most common patent is the "utility" patent, which, in the U.S., is effective for 20 years from the date of filing, unless it was filed prior to 1995, in which case it is effective for 17 years from date of issue, or 20 years from date of application, whichever is later. (answers.com)
  • Developing scientific case strategy for a Hatch-Waxman patent litigation matter. (cov.com)
  • Expert witness in Hatch-Waxman case on Orange Book patent listing and patent term extension issues and general advice to varied pharmaceutical companies in these areas. (cov.com)
  • Representing defendant Asus in case involving 10 patents relating to mobile devices. (alston.com)
  • Representing defendants in a case involving 32 patents relating to DSL technology. (alston.com)
  • Represented plaintiff Nokia in a Lanham Act case involving more than 400 patents related to 3G wireless communication standards. (alston.com)
  • Illegal cholesterol drugs, quick buy blood jewelry viagra vidam vaginal information time veins of generic viagra 50mg likely company meridia, right patent time - likely skin seal amoxicillin viagra case. (autoezda.com)
  • Could the establishment of a patent examination system and new patentability criteria rein in evergreening and lead to lower medicine prices? (msf.org)
  • Kamagra world ruptures general element that acts as a biggest privacy to rein patent topic towards the generic hair of sildenafil old range. (autoezda.com)
  • A "design" patent merely protects a new, original ornamental shape and appearance of a specific class of objects (such as shoe treads, perfume bottles, household appliances), and only for a limited time of 14 years from date of grant. (answers.com)
  • We, the undersigned religious leaders, oppose the patenting of human and animal life-forms. (nih.gov)
  • To capitalize freely upon someone else's patented invention, you would need to find a different way to do the same thing (or wait 20 years, or go overseas), but at least the seed for ingenuity is planted. (answers.com)
  • Patent applications can be difficult to properly draft and usually result in administrative arguments with the patent examiners that can take (literally) years to complete, and there is no guarantee that a patent will ever be issued from a given application. (answers.com)
  • This paper is a review of the work of my former academic group of research in the past 15 years, in the field of cognition enhancers (also called nootropics) that identified two very potent molecules: Unifiram and Sunifiram that for a variety of reasons were not protected by a patent. (nih.gov)
  • If you have a valuable invention, you should seek legal counsel of a registered patent attorney to determine when, where, how and why you should file for a patent. (answers.com)
  • A "ball and ladder game" had been patented in 2001 by Pennsylvanian Robert G. Reid, a postman who had played the game with his family for decades before deciding to file for patent in November, 1999. (wikipedia.org)
  • This is a list of patented and protected hops from the international hop growers convention 2010. (homebrewersassociation.org)
  • One presentation will explore, for example, the difficult challenge of promoting affordable drug development to address health needs faced by developing and middle income nations under the current international patent regime. (iposgoode.ca)
  • In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. (google.com)
  • It has not offered a thorough going analysis of the moral concern associated with genetic screening and testing and the use of genetic knowledge, which would include the issue of patenting. (nih.gov)
  • The therapeutic potential of cannabinoids has been the topic of extensive investigation following the discovery of cannabinoid receptors and their endogenous ligands. (eurekaselect.com)
  • Hot Topic ships to all 50 states, APO/FPO addresses, U.S. territories and possessions and over 150+ countries. (hottopic.com)
  • In the company's most recent patent, it was described as "a tethered ball toss game in which a number of tethered balls arranged at both ends of a series of cords and secured to the ends of the cords by knots are tossed from a prescribed distance toward a number of horizontal bars. (wikipedia.org)